852 Winter Street, Suite 250, Waltham, MA 02451
Zenas BioPharma is incorporated in Delaware.
Zenas BioPharma was founded in 2019.
Zenas BioPharma’s initial public offering (IPO) occurred on September 12, 2024.
Zenas BioPharma’s shares are traded on the Nasdaq Global Select Market under the symbol ZBIO.
Zenas BioPharma’s fiscal year ends on December 31.
Computershare.
By Mail: Computershare, P.O. Box 43006, Providence RI 02940-3006.
By Overnight Delivery: Computershare, 150 Royall St., Suite 101, Canton MA, 02021.
Ropes & Gray LLP
Ernst & Young LLP
Zenas BioPharma’s CUSIP # is 98937L105
Shares of Zenas BioPharma’s stock can be purchased by contacting a securities broker of your choice.
Zenas BioPharma does not currently pay dividends or offer a dividend reinvestment program.
For questions about your stock please contact our transfer agent, Computershare.
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Zenas BioPharma’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please click here to be directed to the email alerts page.
For media inquiries, please send an email to Zenas@argotpartners.com
For investor inquiries, please send an email to Zenas@argotpartners.com